CNO / CNO Financial Group, Inc. - Документы SEC, Годовой отчет, Доверенное заявление

CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) CNO Financial Group, Inc. (Exact Name of Registrant as Specified in its Charter)

Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) CNO Financial Group, Inc.

CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) CNO Financial Group, Inc. (Exact Name of Registrant as Specified in its Charter)

Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) CNO Financial Group, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 Registration Statement Under the Securities Act of 1933 CNO Financial Group, Inc. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 Registration Statement Under the Securities Act of 1933 CNO Financial Group, Inc. (Exact name of registrant as specified in its charter) Delaware 75-3108137 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.) 11299 Illinois Street Carmel, Indiana 46032 (Address of Principal Executive Of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 Registration Statement Under the Securities Act of 1933 CNO Financial Group, Inc. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 Registration Statement Under the Securities Act of 1933 CNO Financial Group, Inc. (Exact name of registrant as specified in its charter) Delaware 75-3108137 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.) 11299 Illinois Street Carmel, Indiana 46032 (Address of Principal Executive Of

c., dated July 31, 2025, redlined for amendments.

Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CNO FINANCIAL GROUP, INC. CNO Financial Group, Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows: 1.The original name of the Corporation was Conseco, Inc. The Corporation’s original Certificate of Incorporation was filed with the Secr

Amended and Restated Certificate of Incorporation of CNO Financial Group, Inc., dated July

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CNO FINANCIAL GROUP, INC. CNO Financial Group, Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows: 1.The original name of the Corporation was Conseco, Inc. The Corporation’s original Certificate of Incorporation was filed with the Secr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CNO Fin

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 28, 2025 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fil

Quarterly Financial Supplement - 2Q2025 July 28, 2025

Quarterly Financial Supplement - 2Q2025 July 28, 2025 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums and insurance policy income 10 Health and life new annualized premiums 11 Computation of weighted average shares outstanding 12 Annuities - account value rollforwards 13 Consolidated statutory information of U.

1 Unless otherwise specified, comparisons in this presentation are between 2Q24 and 2Q25. Second Quarter 2025 Financial and operating results for the period ended June 30, 2025 July 28, 2025 2 Certain statements made in this presentation should be co

1 Unless otherwise specified, comparisons in this presentation are between 2Q24 and 2Q25.

CNO Financial Group Reports Second Quarter 2025 Results Strong production; Solid financial results; On track to deliver 2025-2027 ROE targets

News For Immediate Release CNO Financial Group Reports Second Quarter 2025 Results Strong production; Solid financial results; On track to deliver 2025-2027 ROE targets Carmel, Ind.

CNO Financial Group | Investments Briefing | June 10, 2025 1 CNO Financial Group Investments Briefing June 10, 2025 CNO Financial Group | Investments Briefing | June 10, 2025 2 Welcome Adam Auvil Vice President, Investor Relations & Sustainability CN

a2025investmentsinvestor CNO Financial Group | Investments Briefing | June 10, 2025 1 CNO Financial Group Investments Briefing June 10, 2025 CNO Financial Group | Investments Briefing | June 10, 2025 2 Welcome Adam Auvil Vice President, Investor Relations & Sustainability CNO Financial Group | Investments Briefing | June 10, 2025 3 OUR PURPOSE We secure the future of middle-income America.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 10, 2025 CNO Financial Group

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 10, 2025 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fil

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2025 CNO Financial Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2025 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission File

CNO Financial Group, Inc. Amended and Restated Long-Term Incentive Plan.

Exhibit 10.2 CNO FINANCIAL GROUP, INC. AMENDED AND RESTATED LONG-TERM INCENTIVE PLAN Approved on May 8, 2025 Table of Contents Section Page 1. Purpose 1 2. Definitions 1 3. Administration 4 4. Stock Subject to Plan 5 5. Eligibility; Per-Person Award Limitations 6 6. Specific Terms of Awards 7 7. Performance-Based Compensation 12 8. Certain Provisions Applicable to Awards 12 9. Change in Control 13

Sixth Amendment and Restatement Agreement, dated as of May 8, 2025, among CNO Financial Group, Inc., the lenders party thereto, and KeyBank National Association as administrative agent for the lenders.

exhibit10-1 Exhibit 10.1 1 SIXTH AMENDMENT AND RESTATEMENT AGREEMENT This SIXTH AMENDMENT AND RESTATEMENT AGREEMENT (this “Agreement”) is entered into as of May 8, 2025 among (i) CNO FINANCIAL GROUP, INC., a Delaware corporation (the “Borrower” or the “Company”), (ii) the Lenders (as defined below) executing signatures page hereto, and (iii) KEYBANK NATIONAL ASSOCIATION, as the administrative agen

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Co UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CNO Financia

award agreement for 2025 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.4 CNO FINANCIAL GROUP, INC. 2025 ELG PERFORMANCE SHARE AWARD AGREEMENT CNO Financial Group, Inc., a Delaware corporation (the “Company” or “CNO”), is pleased to advise you that pursuant to the Company’s Amended and Restated Long-Term Incentive Plan (the “Plan”), the Company has granted you an award of the number of performance share units set forth on the Company’s stock plan administra

orm of restricted stock unit award agreement for 2025 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.1 CNO FINANCIAL GROUP, INC. Re: Grant of Restricted Stock Unit Award CNO Financial Group, Inc., a Delaware corporation (the “Company”), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the “Plan”), the Company has granted you an award of the number of restricted share units (the “Restricted Shares”) set forth on the Company’s stock p

d Restatement Long-Term Incentive Plan.

Exhibit 10.3 CNO FINANCIAL GROUP, INC. 2025 PERFORMANCE SHARE AWARD AGREEMENT CNO Financial Group, Inc., a Delaware corporation (the “Company” or “CNO”), is pleased to advise you that pursuant to the Company’s Amended and Restated Long-Term Incentive Plan (the “Plan”), the Company has granted you an award of the number of performance share units set forth on the Company’s stock plan administration

orm of executive leadership group restricted stock unit award agreement for 2025 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.2 CNO FINANCIAL GROUP, INC. Re: Grant of Restricted Stock Unit Award CNO Financial Group, Inc., a Delaware corporation (the ”Company”), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the ”Plan”), the Company has granted you an award of the number of restricted share units (the ”Restricted Shares”) set forth on the Company’s stock p

1 Unless otherwise specified, comparisons in this presentation are between 1Q24 and 1Q25. First Quarter 2025 Financial and operating results for the period ended March 31, 2025 April 28, 2025 2 Certain statements made in this presentation should be c

1 Unless otherwise specified, comparisons in this presentation are between 1Q24 and 1Q25.

Quarterly Financial Supplement - 1Q2025 April 28, 2025

Quarterly Financial Supplement - 1Q2025 April 28, 2025 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums and insurance policy income 10 Health and life new annualized premiums 11 Computation of weighted average shares outstanding 12 Annuities - account value rollforwards 13 Consolidated statutory information of U.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 28, 2025 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fi

CNO Financial Group Reports First Quarter 2025 Results Solid start to 2025; Continuing track record of growth and improved profitability

News For Immediate Release CNO Financial Group Reports First Quarter 2025 Results Solid start to 2025; Continuing track record of growth and improved profitability Carmel, Ind.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of CNO Financial Group, Inc. Name State or Other Jurisdiction 40|86 Advisors, Inc. DE 40|86 Mortgage Capital, Inc. DE American Life and Casualty Marketing Division Co. IA Bankers Conseco Life Insurance Company NY Bankers Life Advisory Services, Inc. IN Bankers Life Agency, Inc. IL Bankers Life and Casualty Company IL Bankers Life Securities General Agency, Inc. IN Bankers

CNO Financial Group, Inc. Insider Securities Trading Policy.

Exhibit 19.1 CNO Financial Group, Inc. INSIDER SECURITIES TRADING POLICY This Insider Securities Trading Policy (this “Policy”) has been adopted by the Board of Directors of CNO Financial Group, Inc., a Delaware corporation (the “Company”). In adopting this Policy, the Board is mindful that the Company has responsibilities to several constituencies and has various objectives and that the manner in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2024 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-31792 CNO Financi

CNO Financial Group Announces $500 Million Increase to Securities Repurchase Authorization and Declares $0.16 Quarterly Dividend Company also announces virtual annual shareholder meeting date

Exhibit 99.1 News For Immediate Release CNO Financial Group Announces $500 Million Increase to Securities Repurchase Authorization and Declares $0.16 Quarterly Dividend Company also announces virtual annual shareholder meeting date CARMEL, Ind., February 12, 2025 – CNO Financial Group, Inc. (NYSE: CNO) announced today that its Board of Directors has approved an additional $500 million to repurchas

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 12, 2025 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 6, 2025 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

Quarterly Financial Supplement - 4Q2024 February 6, 2025

Quarterly Financial Supplement - 4Q2024 February 6, 2025 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums and insurance policy income 10 Health and life new annualized premiums 11 Computation of weighted average shares outstanding 12 Annuities - account value rollforwards 13 Consolidated statutory information of U.

1 Unless otherwise specified, comparisons in this presentation are between 4Q23 and 4Q24. Fourth Quarter 2024 Financial and operating results for the period ended December 31, 2024 February 6, 2025 2 Certain statements made in this presentation shoul

1 Unless otherwise specified, comparisons in this presentation are between 4Q23 and 4Q24.

CNO Financial Group Reports Fourth Quarter and Full Year 2024 Results Exceptional fourth quarter, full-year earnings and sales; Entering 2025 well-positioned for sustainable growth and ROE expansion

News For Immediate Release CNO Financial Group Reports Fourth Quarter and Full Year 2024 Results Exceptional fourth quarter, full-year earnings and sales; Entering 2025 well-positioned for sustainable growth and ROE expansion Carmel, Ind.

CNO Financial Group Names Joel Koehneman as Chief Accounting Officer

Exhibit 99.1 For Immediate Release CNO Financial Group Names Joel Koehneman as Chief Accounting Officer CARMEL, Ind., Jan. 3, 2025 – CNO Financial Group, Inc. (NYSE: CNO) has named Joel Koehneman as Chief Accounting Officer, effective January 21, 2025. He will report to Chief Financial Officer Paul McDonough. “Joel brings extensive experience in public accounting to CNO. He spent 16 years in the a

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

CNO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 2, 2025 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commissi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CN

CNO Financial Group Reports Third Quarter 2024 Results Strong third quarter production; Record annuity collected premiums

News For Immediate Release CNO Financial Group Reports Third Quarter 2024 Results Strong third quarter production; Record annuity collected premiums Carmel, Ind.

1 Unless otherwise specified, comparisons in this presentation are between 3Q23 and 3Q24. Third Quarter 2024 Financial and operating results for the period ended September 30, 2024 October 31, 2024 2 Certain statements made in this presentation shoul

1 Unless otherwise specified, comparisons in this presentation are between 3Q23 and 3Q24.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 31, 2024 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

Quarterly Financial Supplement - 3Q2024 October 31, 2024

Quarterly Financial Supplement - 3Q2024 October 31, 2024 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums and insurance policy income 10 Health and life new annualized premiums 11 Computation of weighted average shares outstanding 12 Annuities - account value rollforwards 13 Consolidated statutory information of U.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

CNO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 1, 2024 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commissi

CNO Financial Group Appoints Jess Turner to its Board of Directors

Exhibit 99.1 For Immediate Release CNO Financial Group Appoints Jess Turner to its Board of Directors CARMEL, Ind., Oct. 1, 2024 – CNO Financial Group, Inc. (NYSE: CNO) announced today that its board of directors has appointed Jess Turner as a director, effective immediately. Turner is Executive Vice President and Global Head of Open Banking and API at Mastercard (NYSE: MA), a global technology co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CNO Fin

incorporated by reference to Exhibit 3.2 of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024.

Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF CNO FINANCIAL GROUP, INC. A Delaware Corporation (Adopted as of August 7, 2024) ARTICLE I. OFFICES Section 1. Registered Office. The registered office of CNO Financial Group, Inc. (the “Corporation”) in the State of Delaware shall be located at 251 Little Falls Drive, Wilmington, DE 19808. The name of the Corporation’s registered agent at such address sh

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2024 CNO Financial Group

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2024 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fil

CNO Financial Group Reports Second Quarter 2024 Results Earnings per share up 66%; Operating earnings per share up 94%

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Second Quarter 2024 Results Earnings per share up 66%; Operating earnings per share up 94% Carmel, Ind., July 29, 2024 - CNO Financial Group, Inc. (NYSE: CNO) today reported net income of $116.3 million, or $1.06 per diluted share, in 2Q24 compared to $73.7 million, or $0.64 per diluted share, in 2Q23. Net operating income (1) was

Quarterly Financial Supplement - 2Q2024 July 29, 2024

Exhibit 99.2 Quarterly Financial Supplement - 2Q2024 July 29, 2024 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums and insurance policy income 10 Health and life new annualized premiums 11 Computation of weighted average shares outstanding 12 Annuities

1 Unless otherwise specified, comparisons in this presentation are between 2Q23 and 2Q24. Second Quarter 2024 Financial and operating results for the period ended June 30, 2024 July 29, 2024 Exhibit 99.3 2 Certain statements made in this presentation

exhibit993 1 Unless otherwise specified, comparisons in this presentation are between 2Q23 and 2Q24.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

CNO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2024 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission F

Third Supplemental Indenture, dated as of May 13, 2024, by and between CNO Financial Group, Inc. and U.S. Bank Trust Company, National Association, as trustee, relating to the 6.450% Senior Notes due 2034.

Exhibit 4.2 Execution Version CNO FINANCIAL GROUP, INC. 6.450% SENIOR NOTES DUE 2034 THIRD SUPPLEMENTAL INDENTURE DATED AS OF May 13, 2024 To the Indenture dated as of June 12, 2019 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 2 SECTION 1.1 Definitions 2 SECTION 1.2 Incorporation by Reference of TIA 5 SECTION

Underwriting Agreement, dated May 8, 2024, among CNO Financial Group, Inc. and Goldman Sach & Co. LLC, RBC Capital Markets, LLC and Barclays Capital Inc., as representatives of the several underwriters named therein, incorporated by reference to Exhibit 1.1 of our Current Report on Form 8-K filed May 13, 2024.

Exhibit 1.1 Execution Version CNO FINANCIAL GROUP, INC. $700,000,000 6.450% SENIOR NOTES DUE 2034 UNDERWRITING AGREEMENT May 8, 2024 May 8, 2024 Goldman Sachs & Co. LLC RBC Capital Markets, LLC Barclays Capital Inc. As Representatives of the several Underwriters c/o Goldman Sachs & Co. LLC 200 West Street New York, New York 10282-2198 c/o RBC Capital Markets, LLC 200 Vesey Street, 8th Floor New Yo

$700,000,000 CNO Financial Group, Inc. 6.450% Senior Notes due 2034

TABLE OF CONTENTS  Filed Pursuant to Rule 424(b)(2)  Registration Statement No. 333-279143 Prospectus Supplement (To Prospectus dated May 6, 2024) $700,000,000 CNO Financial Group, Inc. 6.450% Senior Notes due 2034 CNO Financial Group, Inc., a Delaware corporation (“CNO”), is offering $700,000,000 aggregate principal amount of 6.450% senior notes due 2034 (the “Notes”). The Notes will mature on Ju

Calculation of Filing Fee Table FORM 424B2 (Form Type) CNO Financial Group, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

EXHIBIT 107 Calculation of Filing Fee Table FORM 424B2 (Form Type) CNO Financial Group, Inc.

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2024 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission File

SUBJECT TO COMPLETION, DATED MAY 8, 2024

TABLE OF CONTENTS The information in this prospectus supplement is not complete and may be changed.

CNO Financial Group, Inc. Pricing Term Sheet $700,000,000 6.450% Senior Notes due 2034 (the “Senior Notes Offering”)

Filed Pursuant to Rule 433 Registration No. 333-279143 Issuer Free Writing Prospectus dated May 8, 2024 Relating to Preliminary Prospectus Supplement dated May 8, 2024 Strictly Confidential CNO Financial Group, Inc. Pricing Term Sheet $700,000,000 6.450% Senior Notes due 2034 (the “Senior Notes Offering”) The information in this pricing term sheet relates to the Senior Notes Offering and should be

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CNO Fi

Form of performance stock unit award agreement for 2024 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.4 CNO FINANCIAL GROUP, INC. Re: Grant of Performance Share Award CNO Financial Group, Inc., a Delaware corporation (the “Company” or “CNO”), is pleased to advise you that pursuant to the Company’s Amended and Restated Long-Term Incentive Plan (the “Plan”), the Company has granted you an award of the number of performance share units set forth on the Company’s stock plan administration v

Form of executive leadership group performance stock unit award agreement for 2024 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.2 CNO FINANCIAL GROUP, INC. Re: Grant of Performance Share Award CNO Financial Group, Inc., a Delaware corporation (the “Company” or “CNO”), is pleased to advise you that pursuant to the Company’s Amended and Restated Long-Term Incentive Plan (the “Plan”), the Company has granted you an award of the number of performance share units set forth on the Company’s stock plan administration v

As filed with the Securities and Exchange Commission on May 6, 2024

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on May 6, 2024 Registration No.

Fifth Amendment and Restatement Agreement, dated as of March 30, 2024, among CNO Financial Group, Inc., the lenders party thereto and KeyBank National Association, as administrative agent for the lenders, in respect of the Credit Agreement, dated as of May 19, 2015, among CNO Financial Group, Inc., the lenders party thereto and KeyBank National Association, as administrative agent for the lenders.

Exhibit 10.5 Execution Version FIFTH AMENDMENT AND RESTATEMENT AGREEMENT This FIFTH AMENDMENT AND RESTATEMENT AGREEMENT (this “Agreement”) is entered into as of March 30, 2024 among (i) CNO FINANCIAL GROUP, INC., a Delaware corporation (the “Borrower”), (ii) the Lenders (as defined below) executing signatures page hereto, and (iii) KEYBANK NATIONAL ASSOCIATION, as the administrative agent for the

Form of executive leadership group restricted stock unit award agreement for 2024 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.1 CNO FINANCIAL GROUP, INC. Re: Grant of Restricted Stock Unit Award CNO Financial Group, Inc., a Delaware corporation (the "Company"), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the "Plan"), the Company has granted you an award of the number of restricted share units (the “Restricted Shares”) set forth on the Company’s stock p

Form T-1 Statement of Eligibility in respect of the Indenture

Exhibit 25.1 securities and exchange commission Washington, D.C. 20549 FORM T-1 Statement of Eligibility Under The Trust Indenture Act of 1939 of a Corporation Designated to Act as Trustee Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) ¨ U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E

Form of restricted stock unit award agreement for 2024 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.3 CNO FINANCIAL GROUP, INC. Re: Grant of Restricted Stock Unit Award CNO Financial Group, Inc., a Delaware corporation (the "Company"), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the "Plan"), the Company has granted you an award of the number of restricted share units (the “Restricted Shares”) set forth on the Company’s stock p

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables FORM S-3 (Form Type) CNO Financial Group, Inc.

CNO Financial Group Reports First Quarter 2024 Results Strong sales and distribution force growth; Total new annualized premiums up 8%; Solid first quarter earnings

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports First Quarter 2024 Results Strong sales and distribution force growth; Total new annualized premiums up 8%; Solid first quarter earnings Carmel, Ind., April 29, 2024 - CNO Financial Group, Inc. (NYSE: CNO) today reported net income of $112.3 million, or $1.01 per diluted share, in 1Q24 compared to a net loss of $0.8 million, or $0

1 Unless otherwise specified, comparisons in this presentation are between 1Q23 and 1Q24. First Quarter 2024 Financial and operating results for the period ended March 31, 2024 April 29, 2024 Exhibit 99.3 2 Certain statements made in this presentatio

1 Unless otherwise specified, comparisons in this presentation are between 1Q23 and 1Q24.

Quarterly Financial Supplement - 1Q2024 April 29, 2024

Exhibit 99.2 Quarterly Financial Supplement - 1Q2024 April 29, 2024 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums and insurance policy income 10 Health and life new annualized premiums 11 Computation of weighted average shares outstanding 12 Annuities

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 29, 2024 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fi

DEF 14A

:QVFHQI1PPWN9HHVPQI?THQNGHT AQVP8VHO CNY*3MbXXVggXXZgWeXVgbefabaTgXWgbgX;bTeWbYeXVgbefbYgX kXVhgiXHYYVXefTfWfVbfXWagXIebklLgTgXXag) CNY,3MbeTgYlgXTccbagXagbYIeVXjTgXebhfXTfgXeaTlZgMX ERPQ7NaR FTeV,,'-+-/ 4QZVV MX:aahTFXXgaZf UXaZXWieghTlbal) RbhjUXTUXgbTggXaW gX:aahTFXXgaZ'ibgX TaWfhUglbhedhXfgbaf WheaZgXXXgaZiTiX jXUVTfgUlifgaZ jjj)ieghTfTeXbWXe XXgaZ)Vb*kVTaZXkcXeXaVX 4 ;bTeWKXYeXfXag ,, ;bTeW>iThTgba ,- eXVgbe;bZeTcXf ,.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of CNO Financial Group, Inc. Name State or Other Jurisdiction 40|86 Advisors, Inc. DE 40|86 Mortgage Capital, Inc. DE American Life and Casualty Marketing Division Co. IA Bankers Conseco Life Insurance Company NY Bankers Life Advisory Services, Inc. IN Bankers Life and Casualty Company IL Bankers Life Securities General Agency, Inc. IN Bankers Life Securities, Inc. IN Ben

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2023 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-31792 CNO Financi

CNO Financial Group, Inc. Clawback Policy, incorporated by reference to Exhibit 97.1 of our Annual Report on Form 10-K for the year ended December 31, 2023.

Exhibit 97.1 CNO FINANCIAL GROUP, INC. CLAWBACK POLICY 1. INTRODUCTION. The Board believes that it is in the best interests of the Company and its stockholders to create and maintain a culture that emphasizes integrity and accountability, that reinforces the Company’s pay-for-performance compensation philosophy and deters wrongdoing. In furtherance of the foregoing, the Compensation Committee has

CNO / CNO Financial Group, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0630-cnofinancialgroupinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: CNO Financial Group Inc Title of Class of Securities: Common Stock CUSIP Number: 12621E103 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to

CNO Financial Group Declares $0.15 Quarterly Dividend and Announces Virtual Annual Meeting Date Director Stephen David to retire

Exhibit 99.1 News For Immediate Release CNO Financial Group Declares $0.15 Quarterly Dividend and Announces Virtual Annual Meeting Date Director Stephen David to retire CARMEL, Ind., February 13, 2024 – CNO Financial Group, Inc. (NYSE: CNO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.15 per share on the company’s common shares. The dividend will be paya

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 12, 2024 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

CNO / CNO Financial Group, Inc. / PZENA INVESTMENT MANAGEMENT LLC - SC 13G Passive Investment

SC 13G 1 cnofinancial-13gdec.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 CNO Financial Group Inc (Name of Issuer) COMMON STOCK (Title of Class of Securities) 12621E103 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p

CNO Financial Group Reports Fourth Quarter and Full Year 2023 Results Strong fourth quarter earnings, sustained full-year sales momentum and agent force growth

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Fourth Quarter and Full Year 2023 Results Strong fourth quarter earnings, sustained full-year sales momentum and agent force growth Carmel, Ind., February 6, 2024 - CNO Financial Group, Inc. (NYSE: CNO) today announced its financial results for the fourth quarter and full year ended December 31, 2023. Net income in 4Q23 was $36.3

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 6, 2024 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

Quarterly Financial Supplement - 4Q2023 February 6, 2024

Exhibit 99.2 Quarterly Financial Supplement - 4Q2023 February 6, 2024 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums from annuity and interest sensitive life products and insurance policy income 10 Health and life new annualized premiums 11 Computation

CNO Financial Group 1 Fourth Quarter 2023 Financial and operating results for the period ended December 31, 2023 February 6, 2024 Unless otherwise specified, comparisons in this presentation are between 4Q22 and 4Q23. Exhibit 99.3 CNO Financial Group

CNO Financial Group 1 Fourth Quarter 2023 Financial and operating results for the period ended December 31, 2023 February 6, 2024 Unless otherwise specified, comparisons in this presentation are between 4Q22 and 4Q23.

Certificate of Elimination of Series E Junior Participating Preferred Stock of CNO Financial Group, Inc.

Exhibit 3.2 CERTIFICATE OF ELIMINATION OF THE SERIES E JUNIOR PARTICIPATING PREFERRED STOCK OF CNO FINANCIAL GROUP, INC. Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware CNO Financial Group, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation” or the “Company”), in accordance with the provisions of Section 151(g) of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A/A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 CNO Financial Group, Inc. (Exact name of re

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A/A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 CNO Financial Group, Inc. (Exact name of registrant as specified in its charter) Delaware (State of incorporation or organization) 11825 North Pennsylvania Street Carmel, Indiana (Address of pr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2023 CNO Financial G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

Certificate of Designations of Series F Junior Participating Preferred Stock of CNO Financial Group, Inc., incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K filed November 13, 2023.

Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF SERIES F JUNIOR PARTICIPATING PREFERRED STOCK OF CNO FINANCIAL GROUP, INC. (Pursuant to Section 151 of the General Corporation Law of the State of Delaware) CNO Financial Group, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Company”), hereby certifies that the following resolution was duly adop

Fifth Amended and Restated Section 382 Rights Agreement, dated as of November 10, 2023, between CNO Financial Group, Inc. and Equiniti Trust Company, LLC, as rights agent, which includes the Certificate of Designations for the Series F Junior Participating Preferred Stock as Exhibit A, the Form of Right Certificate as Exhibit B and the Summary of Rights to Purchase Preferred Shares as Exhibit C, incorporated by reference to Exhibit 4.1 of our Current Report on Form 8-K filed November 13, 2023.

Exhibit 4.1 FIFTH AMENDED AND RESTATED SECTION 382 RIGHTS AGREEMENT CNO FINANCIAL GROUP, INC. and EQUINITI TRUST COMPANY, LLC as Rights Agent Dated as of November 10, 2023; effective as of November 13, 2023 TABLE OF CONTENTS Page Section 1. Certain Definitions 3 Section 2. Appointment of Rights Agent 6 Section 3. Issuance of Right Certificates 7 Section 4. Form of Right Certificates 9 Section 5. C

November 10, 2023, between CNO Financial Group, Inc. and Gary C. Bhojwani, incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed November 13, 2023.

Exhibit 10.1 SECOND AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT This SECOND AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT is entered into this 10th day of November, 2023, between CNO Financial Group, Inc., a Delaware corporation (the “Company”), and Gary C. Bhojwani (“Executive”). Recitals A. The Company and Executive entered into an Amended and Restated Employment Agre

CNO Services, LLC Executive Severance Pay Plan, amended and restated effective September 1, 2023.

Exhibit 10.1 CNO SERVICES, LLC EXECUTIVE SEVERANCE PAY PLAN Restated Effective as of September 1, 2023 ARTICLE I. PURPOSE AND TERM OF PLAN 1.1. Purpose of the Plan. The CNO Services, LLC Executive Severance Pay Plan (the "Plan"), as set forth herein, is sponsored by CNO Services, LLC ("Sponsor") and is intended to ease financial hardships which may be experienced by the eligible Employees of an Em

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CN

CNO Financial Group 1 Third Quarter 2023 Financial and operating results for the period ended September 30, 2023 November 6, 2023 Unless otherwise specified, comparisons in this presentation are between 3Q22 and 3Q23. Exhibit 99.3 CNO Financial Group

exhibit993 CNO Financial Group 1 Third Quarter 2023 Financial and operating results for the period ended September 30, 2023 November 6, 2023 Unless otherwise specified, comparisons in this presentation are between 3Q22 and 3Q23.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2023 CNO Financial Gr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

CNO Financial Group Reports Third Quarter 2023 Results Solid third quarter results, total new annualized premiums up 13%

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Third Quarter 2023 Results Solid third quarter results, total new annualized premiums up 13% Carmel, Ind., November 6, 2023 - CNO Financial Group, Inc. (NYSE: CNO) today reported net income of $167.3 million, or $1.46 per diluted share, in 3Q23 compared to $175.9 million, or $1.52 per diluted share, in 3Q22. Net operating income (

Quarterly Financial Supplement - 3Q2023 November 6, 2023

Exhibit 99.2 Quarterly Financial Supplement - 3Q2023 November 6, 2023 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums from annuity and interest sensitive life products and insurance policy income 10 Health and life new annualized premiums 11 Computation

CNO Financial Group Names Michellen Wildin Senior Vice President and Chief Accounting Officer

Exhibit 99.1 News For Immediate Release CNO Financial Group Names Michellen Wildin Senior Vice President and Chief Accounting Officer CARMEL, Ind., October 16, 2023 /PRNewswire/ - CNO Financial Group, Inc. (NYSE: CNO) has named Michellen Wildin senior vice president of accounting effective October 23, 2023, and chief accounting officer (CAO) effective January 1, 2024. She will report to Chief Fina

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 16, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

June 30, 2023 December 31, 2022 Fixed indexed annuity insurance liabilities Host contract liability $8,035.3 $7,856.4 Embedded derivatives at market 1,355.4 1,297.0 Total fixed indexed annuity insurance liabilities $9,390.7 $9,153.4

October 13, 2023 Michael Volley/Benjamin Phippen Securities and Exchange Commission Division of Corporate Finance Washington, D.

CNO Financial Group 1 Investor Overview August 2023 Exhibit 99.1 CNO Financial Group 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litig

exhibit991 CNO Financial Group 1 Investor Overview August 2023 Exhibit 99.1 CNO Financial Group 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that these fo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 10, 2023 CNO Financial Gro

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 10, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CNO Fin

Fourth Amendment and Restatement Agreement, dated as of May 4, 2023, among CNO Financial Group, Inc., the lenders party thereto, and KeyBank National Association, as administrative agent for the lenders, in respect of the Credit Agreement, dated as of May 19, 2015, among CNO Financial Group, Inc., the lenders party thereto, and KeyBank National Association, as administrative agent for the lenders.

Exhibit 10.1 Execution Version FOURTH AMENDMENT AND RESTATEMENT AGREEMENT This FOURTH AMENDMENT AND RESTATEMENT AGREEMENT (this “Agreement”) is entered into as of May 4, 2023 among (i) CNO FINANCIAL GROUP, INC., a Delaware corporation (the “Borrower”), (ii) the Lenders (as defined below) executing signatures page hereto, and (iii) KEYBANK NATIONAL ASSOCIATION, as the administrative agent for the L

Quarterly Financial Supplement - 2Q2023 July 31, 2023

Exhibit 99.2 Quarterly Financial Supplement - 2Q2023 July 31, 2023 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums from annuity and interest sensitive life products and insurance policy income 10 Health and life new annualized premiums 11 Computation of

CNO Financial Group 1 Second Quarter 2023 Financial and operating results for the period ended June 30, 2023 July 31, 2023 Unless otherwise specified, comparisons in this presentation are between 2Q22 and 2Q23. Exhibit 99.3 CNO Financial Group 2 Impo

exhibit993 CNO Financial Group 1 Second Quarter 2023 Financial and operating results for the period ended June 30, 2023 July 31, 2023 Unless otherwise specified, comparisons in this presentation are between 2Q22 and 2Q23.

CNO Financial Group Reports Second Quarter 2023 Results Total new annualized premiums up 11%; strong capital position

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Second Quarter 2023 Results Total new annualized premiums up 11%; strong capital position Carmel, Ind., July 31, 2023 - CNO Financial Group, Inc. (NYSE: CNO) today reported net income of $73.7 million, or $0.64 per diluted share, in 2Q23 compared to $233.3 million, or $1.99 per diluted share, in 2Q22. Net operating income (1) was

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 31, 2023 CNO Financial Group

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 31, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fil

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 5, 2023 CNO Financial Group,

CNO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 5, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 19, 2023 CNO Financial Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 19, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission File

CNO Financial Group 1 Investor Overview May 2023 Exhibit 99.1 CNO Financial Group 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigati

exhibit991 CNO Financial Group 1 Investor Overview May 2023 Exhibit 99.1 CNO Financial Group 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that these forwa

Form of executive leadership group restricted stock unit award agreement for 2023 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.1 CNO FINANCIAL GROUP, INC. Re: Grant of Restricted Stock Unit Award CNO Financial Group, Inc., a Delaware corporation (the "Company"), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the "Plan"), the Company has granted you an award of the number of restricted share units (the “Restricted Shares”) set forth on the Company’s stock p

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 CNO Financial Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission File

Form of executive leadership group performance stock unit award agreement for 2023 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.2 CNO FINANCIAL GROUP, INC. Re: Grant of Performance Share Award CNO Financial Group, Inc., a Delaware corporation (the "Company"), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the "Plan"), the Company has granted you an award of the number of performance share units set forth on the Company’s stock plan administration vendor’s w

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CNO Fi

Form of restricted stock unit award agreement for 2023 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.3 CNO FINANCIAL GROUP, INC. Re: Grant of Restricted Stock Unit Award CNO Financial Group, Inc., a Delaware corporation (the "Company"), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the "Plan"), the Company has granted you an award of the number of restricted share units (the “Restricted Shares”) set forth on the Company’s stock p

Form of performance stock unit award agreement for 2023 under the Amended and Restated Long-Term Incentive Plan.

Exhibit 10.4 CNO FINANCIAL GROUP, INC. Re: Grant of Performance Share Award CNO Financial Group, Inc., a Delaware corporation (the "Company"), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the "Plan"), the Company has granted you an award of the number of performance share units set forth on the Company’s stock plan administration vendor’s w

CNO Financial Group Announces Additional $500 Million to Securities Repurchase Authorization and Increase of Quarterly Dividend to $0.15

Exhibit 99.1 News For Immediate Release CNO Financial Group Announces Additional $500 Million to Securities Repurchase Authorization and Increase of Quarterly Dividend to $0.15 CARMEL, Ind., May 5, 2023 – CNO Financial Group, Inc. (NYSE: CNO) announced today that its Board of Directors has approved an additional $500 million to repurchase the company's outstanding common stock. As of March 31, 202

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 5, 2023 CNO Financial Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 5, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission File

CNO Financial Group 1 First Quarter 2023 Financial and operating results for the period ended March 31, 2023 May 1, 2023 Unless otherwise specified, comparisons in this presentation are between 1Q22 and 1Q23. Exhibit 99.3 CNO Financial Group 2 Import

exhibit993 CNO Financial Group 1 First Quarter 2023 Financial and operating results for the period ended March 31, 2023 May 1, 2023 Unless otherwise specified, comparisons in this presentation are between 1Q22 and 1Q23.

Quarterly Financial Supplement - 1Q2023 The information in this quarterly financial supplement is unaudited and prior periods have been recast to aid users of our financial statements in understanding the impacts of adopting ASU 2018-12 related to ta

Exhibit 99.2 Quarterly Financial Supplement - 1Q2023 The information in this quarterly financial supplement is unaudited and prior periods have been recast to aid users of our financial statements in understanding the impacts of adopting ASU 2018-12 related to targeted improvements to the accounting for long-duration insurance contracts. It is possible that the financial results included in our fu

Quarterly Financial Supplement - 4Q2022 as Recast to Reflect the Adoption of ASU 2018-12 The information in this recast quarterly financial supplement is unaudited and is being provided to aid users of our financial statements in understanding the im

Exhibit 99.4 Quarterly Financial Supplement - 4Q2022 as Recast to Reflect the Adoption of ASU 2018-12 The information in this recast quarterly financial supplement is unaudited and is being provided to aid users of our financial statements in understanding the impacts of adopting ASU 2018-12 related to targeted improvements to the accounting for long-duration insurance contracts. It is possible th

CNO Financial Group Reports First Quarter 2023 Results Total new annualized premiums up 7% Capital and liquidity remain above target levels

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports First Quarter 2023 Results Total new annualized premiums up 7% Capital and liquidity remain above target levels Carmel, Ind., May 1, 2023 - CNO Financial Group, Inc. (NYSE: CNO) today reported a net loss of $0.8 million, or $0.01 per diluted share, in 1Q23 compared to net income of $183.4 million, or $1.52 per diluted share, in 1Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 1, 2023 CNO Financial Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 1, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission File

DEF 14A

2023 Annual Meeting of Shareholders Proxy StatementNoticeofAnnualMeetingofShareholders VotingItems Proposal 1: To elect the nine directors nominated to the Board of Directors of the Company and named in the Proxy Statement, each for a one-year term ending in 2024.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rul

CNO Financial Group 1 Investor Overview February 2023 Exhibit 99.1 CNO Financial Group 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Lit

exhibit991 CNO Financial Group 1 Investor Overview February 2023 Exhibit 99.1 CNO Financial Group 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that these

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2023 CNO Financial G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-31792 CNO Financi

Subsidiaries of the Registrant.

Exhibit 21 Subsidiaries of CNO Financial Group, Inc. Name State or Other Jurisdiction 40|86 Advisors, Inc. DE 40|86 Mortgage Capital, Inc. DE American Life and Casualty Marketing Division Co. IA Bankers Conseco Life Insurance Company NY Bankers Life Advisory Services, Inc. IN Bankers Life and Casualty Company IL Bankers Life Securities General Agency, Inc. IN Bankers Life Securities, Inc. IN Benet

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 23, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

CNO Financial Group 1 CNO Financial Group Investor Day February 23, 2023 Exhibit 99.1 CNO Financial Group | Investor Day | February 23, 2023 2 Certain statements made in this presentation should be considered forward-looking statements as defined in

exhibit991 CNO Financial Group 1 CNO Financial Group Investor Day February 23, 2023 Exhibit 99.

CNO Financial Group Nominates Archie Brown and Adrianne Lee to its Board of Directors, Directors Ellyn Brown and Fred Sievert to Retire

Exhibit 99.1 News For Immediate Release CNO Financial Group Nominates Archie Brown and Adrianne Lee to its Board of Directors, Directors Ellyn Brown and Fred Sievert to Retire CARMEL, Ind., February 15, 2023 - CNO Financial Group, Inc. (NYSE: CNO) today announced that its Board of Directors has nominated Archie Brown and Adrianne Lee as directors to stand for election at the company’s May 10, 2023

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 14, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

CNO Financial Group Declares $0.14 Quarterly Dividend and Announces Virtual Annual Meeting Date

Exhibit 99.2 News For Immediate Release CNO Financial Group Declares $0.14 Quarterly Dividend and Announces Virtual Annual Meeting Date CARMEL, Ind., February 15, 2023 – CNO Financial Group, Inc. (NYSE: CNO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.14 per share on the company’s common shares. The dividend will be payable March 24, 2023, to shareholde

CNO / CNO Financial Group Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0605-cnofinancialgroupinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: CNO Financial Group Inc. Title of Class of Securities: Common Stock CUSIP Number: 12621E103 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box t

CNO Financial Group 1 Fourth Quarter 2022 Financial and operating results for the period ended December 31, 2022 February 7, 2023 Unless otherwise specified, comparisons in this presentation are between 4Q21 and 4Q22. Exhibit 99.3 CNO Financial Group

CNO Financial Group 1 Fourth Quarter 2022 Financial and operating results for the period ended December 31, 2022 February 7, 2023 Unless otherwise specified, comparisons in this presentation are between 4Q21 and 4Q22.

CNO Financial Group Reports Fourth Quarter and Full Year 2022 Results 2022 sales momentum has CNO well-positioned for 2023 and beyond

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Fourth Quarter and Full Year 2022 Results 2022 sales momentum has CNO well-positioned for 2023 and beyond Carmel, Ind., February 7, 2023 - CNO Financial Group, Inc. (NYSE: CNO) today announced that for the quarter ended December 31, 2022, net income was $43.4 million, or $0.37 per diluted share, compared to $115.8 million, or $0.9

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 7, 2023 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

Quarterly Financial Supplement - 4Q2022 February 7, 2023

EX-99.2 3 exhibit992-12312022investo.htm EX-99.2 Exhibit 99.2 Quarterly Financial Supplement - 4Q2022 February 7, 2023 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Estimated impacts of COVID-19 on insurance product margins 10 Collected premiums from annuity and interes

CNO / CNO Financial Group Inc / PZENA INVESTMENT MANAGEMENT LLC - SC 13G/A Passive Investment

SC 13G/A 1 pzn-sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G AMENDMENT NO 2 Under the Securities Exchange Act of 1934 CNO FINANCIAL GROUP, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 12621E103 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat

Amended and Restated By-Laws of CNO Financial Group, Inc., redlined for amendments.

AMENDED AND RESTATED BY-LAWS OF CNO FINANCIAL GROUP, INC. A Delaware Corporation (Adopted as of February 20, 2019December 13, 2022) A RTICLE I. OFFICES Section 1. Registered Office. The registered office of CNO Financial Group, Inc. (the ?Corporation?) in the State of Delaware shall be located at 2711 Centerville Road, Suite 400251 Little Falls Drive, Wilmington, DE 1980119808. The name of the Cor

Amended and Restated Bylaws of CNO Financial Group, Inc., incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K filed December 14, 2022.

Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF CNO FINANCIAL GROUP, INC. A Delaware Corporation (Adopted as of December 13, 2022) ARTICLE I. OFFICES Section 1. Registered Office. The registered office of CNO Financial Group, Inc. (the ?Corporation?) in the State of Delaware shall be located at 251 Little Falls Drive, Wilmington, DE 19808. The name of the Corporation?s registered agent at such address

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 13, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

CNO Financial Group Elevates Executive Leadership Roles, Names Jean Linnenbringer Chief Operations Officer and Mike Mead Chief Information Officer

Exhibit 99.1 News CNO Financial Group Elevates Executive Leadership Roles, Names Jean Linnenbringer Chief Operations Officer and Mike Mead Chief Information Officer CARMEL, Ind., December 8, 2022 /PRNewswire/ - CNO Financial Group, Inc. (NYSE: CNO) today announced it is elevating two key senior leaders to the company?s Executive Leadership Group: Jean Linnenbringer as chief operations officer and

Consulting Agreement, dated December 6, 2022, between CNO Services, LLC and Bruce K. Baude

Exhibit 10.1 CNO Services, LLC December 6, 2022 Bruce K. Baude Re: Consulting Agreement Dear Bruce, This letter agreement (this ?Agreement?) is intended to confirm our mutual understanding with respect to your limited engagement as a consultant for CNO Services, LLC (the ?Company?). By signing below, you represent and warrant that you are under no obligation to any third-party that would interfere

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 6, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

CNO Financial Group 1 Investor Overview November 2022 Exhibit 99.1 CNO Financial Group 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Lit

CNO Financial Group 1 Investor Overview November 2022 Exhibit 99.1 CNO Financial Group 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that these forward-loo

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 15, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CN

CNO Financial Group 1 Third Quarter 2022 Financial and operating results for the period ended September 30, 2022 October 31, 2022 Unless otherwise specified, comparisons in this presentation are between 3Q21 and 3Q22. Exhibit 99.3 CNO Financial Group

CNO Financial Group 1 Third Quarter 2022 Financial and operating results for the period ended September 30, 2022 October 31, 2022 Unless otherwise specified, comparisons in this presentation are between 3Q21 and 3Q22.

Quarterly Financial Supplement - 3Q2022 October 31, 2022

Exhibit 99.2 Quarterly Financial Supplement - 3Q2022 October 31, 2022 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Estimated impacts of COVID-19 on insurance product margins 10 Collected premiums from annuity and interest sensitive life products and insurance policy in

CNO Financial Group Reports Third Quarter 2022 Results Solid third quarter results with earnings per share up 18%, continued strong sales momentum

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Third Quarter 2022 Results Solid third quarter results with earnings per share up 18%, continued strong sales momentum Carmel, Ind., October 31, 2022 - CNO Financial Group, Inc. (NYSE: CNO) today announced that for the quarter ended September 30, 2022, net income was $105.0 million, or $0.91 per diluted share, compared to $99.8 mi

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 31, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

CNO Financial Group 1 Investor Overview August 2022 Exhibit 99.1 CNO Financial Group 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litig

CNO Financial Group 1 Investor Overview August 2022 Exhibit 99.1 CNO Financial Group 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that these forward-looki

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 26, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CNO Fin

Amended and Restated Certificate of Incorporation of CNO Financial Group, Inc., incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K filed August 1, 2022.

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CNO FINANCIAL GROUP, INC. CNO Financial Group, Inc. (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows: 1.The original name of the Corporation was Conseco, Inc. The Corporation?s original Certificate of Incorporation was filed with the Secr

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fil

CNO Financial Group Reports Second Quarter 2022 Results Strong second quarter with earnings per share up 100% and operating earnings per share up 29%

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Second Quarter 2022 Results Strong second quarter with earnings per share up 100% and operating earnings per share up 29% Carmel, Ind., August 1, 2022 - CNO Financial Group, Inc. (NYSE: CNO) today announced that for the quarter ended June 30, 2022, net income was $136.1 million, or $1.16 per diluted share, compared to $78.0 millio

CNO Financial Group 1 Second Quarter 2022 Financial and operating results for the period ended June 30, 2022 August 1, 2022 Unless otherwise specified, comparisons in this presentation are between 2Q21 and 2Q22. Exhibit 99.3 CNO Financial Group 2 Imp

CNO Financial Group 1 Second Quarter 2022 Financial and operating results for the period ended June 30, 2022 August 1, 2022 Unless otherwise specified, comparisons in this presentation are between 2Q21 and 2Q22.

Quarterly Financial Supplement - 2Q2022 August 1, 2022

Exhibit 99.2 Quarterly Financial Supplement - 2Q2022 August 1, 2022 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Estimated impacts of COVID-19 on insurance product margins 10 Collected premiums from annuity and interest sensitive life products and insurance policy inco

Amended and Restated Certificate of Incorporation of CNO Financial Group, Inc., redlined for amendments.

Exhibit 3.1.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CNO FINANCIAL GROUP, INC. CNO Financial Group, Inc. (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows: 1.The original name of the Corporation was Conseco, Inc. The Corporation?s original Certificate of Incorporation was filed with the Se

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 19, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CNO Fi

Form of performance stock unit award agreement for 2022 under the Amended and Restated Long-Term Incentive Plan

Exhibit 10.2 CNO FINANCIAL GROUP, INC. Re: Grant of Performance Share Award CNO Financial Group, Inc., a Delaware corporation (the "Company"), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the "Plan"), the Company has granted you an award of the number of performance share units set forth on the Company?s stock plan administration vendor?s w

Form of restricted stock unit award agreement for 2022 under the Amended and Restated Long-Term Incentive Plan

Exhibit 10.1 CNO FINANCIAL GROUP, INC. Re: Grant of Restricted Stock Unit Award CNO Financial Group, Inc., a Delaware corporation (the "Company"), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the "Plan"), the Company has granted you an award of the number of restricted share units (the ?Restricted Shares?) set forth on the Company?s stock p

CNO Financial Group Reports First Quarter 2022 Results Solid production, agent productivity and capital return; $100 million in share repurchases

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports First Quarter 2022 Results Solid production, agent productivity and capital return; $100 million in share repurchases Carmel, Ind., May 2, 2022 - CNO Financial Group, Inc. (NYSE: CNO) today announced that for the quarter ended March 31, 2022, net income was $112.3 million, or $0.93 per diluted share, compared to $147.4 million, or

Quarterly Financial Supplement - 1Q2022 May 2, 2022

Exhibit 99.2 Quarterly Financial Supplement - 1Q2022 May 2, 2022 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Estimated impacts of COVID-19 on insurance product margins 10 Collected premiums from annuity and interest sensitive life products and insurance policy income

CNO Financial Group 1 First Quarter 2022 Financial and operating results for the period ended March 31, 2022 May 2, 2022 Unless otherwise specified, comparisons in this presentation are between 1Q21 and 1Q22. Exhibit 99.3 CNO Financial Group 2 Import

CNO Financial Group 1 First Quarter 2022 Financial and operating results for the period ended March 31, 2022 May 2, 2022 Unless otherwise specified, comparisons in this presentation are between 1Q21 and 1Q22.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 2, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ????) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by R

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 TRANSITION REPORT PURSUANT TO SECTION 1

Table of Contents Table of Contents Table of Contents A Letter to Shareholders from CEO Gary C.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ????) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? D

COURTESY PDF

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ????) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by R

Subsidiaries of the Registrant.

Exhibit 21 Subsidiaries of CNO Financial Group, Inc. Name State or Other Jurisdiction 40|86 Advisors, Inc. DE 40|86 Mortgage Capital, Inc. DE American Life and Casualty Marketing Division Co. IA Bankers Conseco Life Insurance Company NY Bankers Life Advisory Services, Inc. IN Bankers Life and Casualty Company IL Bankers Life Securities General Agency, Inc. IN Bankers Life Securities, Inc. IN Benet

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-31792 CNO Financi

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

Investor Overview February 2022 Exhibit 99.1 CNO Financial Group | Investor Overview | February 2022 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private

Investor Overview February 2022 Exhibit 99.1 CNO Financial Group | Investor Overview | February 2022 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that the

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 16, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

CNO Financial Group Declares Quarterly Dividend and Announces Virtual Annual Meeting Date Director Robert Greving to retire

Exhibit 99.1 News For Immediate Release CNO Financial Group Declares Quarterly Dividend and Announces Virtual Annual Meeting Date Director Robert Greving to retire CARMEL, Ind., February 16, 2022 ? CNO Financial Group, Inc. (NYSE: CNO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.13 per share on the company?s common shares. The dividend will be payable M

CNO / CNO Financial Group Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: CNO Financial Group Inc. Title of Class of Securities: Common Stock CUSIP Number: 12621E103 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is fi

Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 8, 2022 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

CNO / CNO Financial Group Inc / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10 )* CNO Financial Group Inc (Name of Issuer) Common Stock (Title of Class of Securities) 12621E103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th

CNO Financial Group Reports Fourth Quarter and Full Year 2021 Results Strong fourth quarter and full year results; double-digit EPS growth; record 2021 share repurchases

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Fourth Quarter and Full Year 2021 Results Strong fourth quarter and full year results; double-digit EPS growth; record 2021 share repurchases Carmel, Ind., February 8, 2022 - CNO Financial Group, Inc. (NYSE: CNO) today announced that for the quarter ended December 31, 2021, net income was $115.8 million, or $0.93 per diluted share

Quarterly Financial Supplement - 4Q2021 February 8, 2022

Exhibit 99.2 Quarterly Financial Supplement - 4Q2021 February 8, 2022 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Estimated impacts of COVID-19 on insurance product margins 10 Collected premiums from annuity and interest sensitive life products and insurance policy in

Fourth Quarter 2021 Financial and operating results for the period ended December 31, 2021 February 8, 2022 Unless otherwise specified, comparisons in this presentation are between 4Q20 and 4Q21. Exhibit 99.3 CNO Financial Group | Fourth Quarter 2021

Fourth Quarter 2021 Financial and operating results for the period ended December 31, 2021 February 8, 2022 Unless otherwise specified, comparisons in this presentation are between 4Q20 and 4Q21.

CNO / CNO Financial Group Inc / PZENA INVESTMENT MANAGEMENT LLC - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G AMENDMENT NO 1 Under the Securities Exchange Act of 1934 CNO FINANCIAL GROUP, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 12621E103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 9, 2021 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

Investor Overview December 2021 Exhibit 99.1 CNO Financial Group | Investor Overview | December 2021 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private

Investor Overview December 2021 Exhibit 99.1 CNO Financial Group | Investor Overview | December 2021 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CN

Third Quarter 2021 Financial and operating results for the period ended September 30, 2021 October 27, 2021 Unless otherwise specified, comparisons in this presentation are between 3Q20 and 3Q21. Exhibit 99.3 CNO Financial Group | Third Quarter 2021

EX-99.3 4 exhibit993.htm EX-99.3 Third Quarter 2021 Financial and operating results for the period ended September 30, 2021 October 27, 2021 Unless otherwise specified, comparisons in this presentation are between 3Q20 and 3Q21. Exhibit 99.3 CNO Financial Group | Third Quarter 2021 Earnings | October 27, 2021 2 Important Legal Information Certain statements made in this presentation should be cons

Quarterly Financial Supplement - 3Q2021 October 27, 2021

Exhibit 99.2 Quarterly Financial Supplement - 3Q2021 October 27, 2021 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Estimated impacts of COVID-19 on insurance product margins 10 Collected premiums from annuity and interest sensitive life products and insurance policy in

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 27, 2021 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

CNO Financial Group Reports Third Quarter 2021 Results Solid third quarter performance; sales and collected premiums exceed pre-pandemic levels; completed $115 million in share repurchases

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Third Quarter 2021 Results Solid third quarter performance; sales and collected premiums exceed pre-pandemic levels; completed $115 million in share repurchases Carmel, Ind., October 27, 2021 - CNO Financial Group, Inc. (NYSE: CNO) today announced that for the quarter ending September 30, 2021, net income was $99.8 million, or $0.

Investor Overview August 2021 Exhibit 99.1 CNO Financial Group | Investor Overview | August 2021 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Secu

Investor Overview August 2021 Exhibit 99.1 CNO Financial Group | Investor Overview | August 2021 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that these f

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 16, 2021 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CNO Fin

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 28, 2021 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fil

CNO Financial Group Reports Second Quarter 2021 Results Strong second quarter results; total sales exceed pre-pandemic 2019 levels; $87 million in share repurchases

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Second Quarter 2021 Results Strong second quarter results; total sales exceed pre-pandemic 2019 levels; $87 million in share repurchases Carmel, Ind., July 28, 2021 - CNO Financial Group, Inc. (NYSE: CNO) today announced that for the quarter ending June 30, 2021, net income was $78.0 million, or $0.58 per diluted share, compared t

Quarterly Financial Supplement - 2Q2021 July 28, 2021

Exhibit 99.2 Quarterly Financial Supplement - 2Q2021 July 28, 2021 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Estimated impacts of COVID-19 on insurance product margins 10 Collected premiums from annuity and interest sensitive life products and insurance policy incom

Second Quarter 2021 Financial and operating results for the period ended June 30, 2021 July 28, 2021 Unless otherwise specified, comparisons in this presentation are between 2Q20 and 2Q21. Exhibit 99.3 CNO Financial Group | Second Quarter 2021 Earnin

Second Quarter 2021 Financial and operating results for the period ended June 30, 2021 July 28, 2021 Unless otherwise specified, comparisons in this presentation are between 2Q20 and 2Q21.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 16, 2021 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fil

Second Amendment and Restatement Agreement, dated as of July 16, 2021, among CNO Financial Group, Inc., the lenders party thereto, and KeyBank National Association, as administrative agent for the lenders, in respect of the Credit Agreement, dated as of May 19, 2015, among CNO Financial Group, Inc., the lenders party thereto, and KeyBank National Association, as administrative agent for the lenders

Exhibit 10.1 Execution Version SECOND AMENDMENT AND RESTATEMENT AGREEMENT This SECOND AMENDMENT AND RESTATEMENT AGREEMENT (this ?Agreement?) is entered into as of July 16, 2021 among (i) CNO FINANCIAL GROUP, INC., a Delaware corporation (the ?Borrower?), (ii) the Lenders (as defined below) executing signatures page hereto, and (iii) KEYBANK NATIONAL ASSOCIATION, as the administrative agent for the

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 13, 2021 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission File

Investor Overview May 2021 Exhibit 99.1 CNO Financial Group | Investor Overview | May 2021 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities

Investor Overview May 2021 Exhibit 99.1 CNO Financial Group | Investor Overview | May 2021 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that these forward

Form T-1 Statement of Eligibility in respect of the Indenture.

Exhibit 25.1 securities and exchange commission Washington, D.C. 20549 FORM T-1 Statement of Eligibility Under The Trust Indenture Act of 1939 of a Corporation Designated to Act as Trustee Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) ? U.S. BANK NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 31-0841368 I.R.S. Employer Identif

Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2021 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission File

- S-3ASR

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on May 10, 2021 Registration No.

CNO Financial Group Announces Increase to Securities Repurchase Authorization, Increase to Quarterly Dividend and Results of Annual Shareholder Meeting

Exhibit 99.1 News For Immediate Release CNO Financial Group Announces Increase to Securities Repurchase Authorization, Increase to Quarterly Dividend and Results of Annual Shareholder Meeting CARMEL, Ind., May 7, 2021 ? CNO Financial Group, Inc. (NYSE: CNO) announced today that its Board of Directors has approved an additional $500 million to repurchase the company?s outstanding common stock. At M

Form of performance stock unit award agreement for 2021 under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.2 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021.

EX-10.2 3 cno03312021ex102.htm EX-10.2 Exhibit 10.2 CNO FINANCIAL GROUP, INC. Re: Grant of Performance Share Award CNO Financial Group, Inc., a Delaware corporation (the "Company"), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the "Plan"), the Company has granted you an award of the number of performance share units set forth on the Company

Form of restricted stock unit award agreement for 2021 under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.1 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021.

Exhibit 10.1 CNO FINANCIAL GROUP, INC. Re: Grant of Restricted Stock Unit Award CNO Financial Group, Inc., a Delaware corporation (the "Company"), is pleased to advise you that pursuant to the Company's Amended and Restated Long-Term Incentive Plan (the "Plan"), the Company has granted you an award of the number of restricted share units (the ?Restricted Shares?) set forth on the Company?s stock p

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-31792 CNO Fi

Financial and operating results for the period ended March 31, 2021 April 28, 2021 Unless otherwise specified, comparisons in this presentation are between 1Q20 and 1Q21. Exhibit 99.3 CNO Financial Group | First Quarter 2021 Earnings | April 28, 2021

Financial and operating results for the period ended March 31, 2021 April 28, 2021 Unless otherwise specified, comparisons in this presentation are between 1Q20 and 1Q21.

CNO Financial Group Reports First Quarter 2021 Results Solid first quarter earnings; sales momentum returning to pre-pandemic levels; completed $100 million in share repurchases

EX-99.1 2 exhibit991-03312021earnings.htm EX-99.1 Exhibit 99.1 News For Immediate Release CNO Financial Group Reports First Quarter 2021 Results Solid first quarter earnings; sales momentum returning to pre-pandemic levels; completed $100 million in share repurchases Carmel, Ind., April 28, 2021 - CNO Financial Group, Inc. (NYSE: CNO) today announced that for the quarter ending March 31, 2021, net

Quarterly Financial Supplement - 1Q2021 April 28, 2021

Exhibit 99.2 Quarterly Financial Supplement - 1Q2021 April 28, 2021 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums from annuity and interest sensitive life products and insurance policy income 10 Health and life new annualized premiums 11 Computation o

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 28, 2021 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fi

The portions of the Definitive Proxy Statement filed on March 26, 2021 incorporated by reference into Part III of our 2020 Form 10-K; and

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.????) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by Ru

- ANNUAL REPORT TO SECURITY HOLDERS

Table of Contents A Letter to Shareholders from CEO Gary C. Bhojwani 2 Annual Report on Form 10-K 6 Market for Registrant?s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 39 Management?s Discussion and Analysis of Consolidated Financial Condition and Results of Operations 42 Consolidated Financial Statements 73 Exhibits and Financial Statement Schedules 134 Di

DEF 14A

2021 Annual Meeting of Shareholders Proxy StatementNoticeofAnnualMeetingofShareholders Voting Items Proposal 1: To elect the 10 directors nominated to the Board of Directors of the Company and named in the Proxy Statement, each for a one-year term ending in 2022.

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin

- PRE 14A

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.????) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by Ru

Investor Overview March 2021 Exhibit 99.1 CNO Financial Group | Investor Overview | March 2021 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securi

EX-99.1 2 exhibit991032021.htm EX-99.1 Investor Overview March 2021 Exhibit 99.1 CNO Financial Group | Investor Overview | March 2021 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital pla

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 10, 2021 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission Fi

incorporated by reference to Exhibit 10.20 of our Annual Report on Form 10-K for the year ended December 31, 2020

EX-10.20 5 cno12312020ex1020.htm EX-10.20 Exhibit 10.20 THIRD AMENDMENT OF THE CNO DEFERRED COMPENSATION PLAN THIS THIRD AMENDMENT OF THE CNO DEFERRED COMPENSATION PLAN (Amended and Restated Effective as of January 1, 2017) (the “Plan”) is made by CNO Services, LLC (the “Company”), pursuant to action of the Company’s Manager (the “Manager”), effective January 1, 2021 (the “Effective Date”). WHEREA

Amendment Number One to the CNO Services, LLC Executive Severance Pay Plan

Exhibit 10.34 AMENDMENT NUMBER ONE TO THE CNO SERVICES, LLC EXECUTIVE SEVERANCE PAY PLAN THIS AMENDMENT NUMBER ONE to the CNO Services, LLC Executive Severance Pay Plan is executed this 21st day of December, 2020, to be effective as of October 1, 2020 (the "Effective Date") by CNO Services, LLC (the "Company"). WITNESSETH: WHEREAS, the Company established and maintains the CNO Services, LLC Execut

incorporated by reference to Exhibit 10.25 of our Annual Report on Form 10-K for the year ended December 31, 2020

Exhibit 10.25 FIRST AMENDMENT OF THE CNO BOARD OF DIRECTORS DEFERRED COMPENSATION PLAN THIS FIRST AMENDMENT OF THE CNO BOARD OF DIRECTORS DEFERRED COMPENSATION PLAN (Amended and Restated Effective as of January 1, 2017) (the “Plan”) is made by CNO Financial Group, Inc. (the “Company”), pursuant to action of the Human Resources and Compensation Committee of the Board of Directors, effective January

Description of the registrant's securities registered pursuant to Section 12 of the Securities Exchange Act of 1934

Exhibit 4.11 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The definitions of certain capitalized terms used in the following description are set forth below under ?? Certain Definitions.? The terms ?the Company,? ?we,? ?our? and ?us? refer solely to CNO Financial Group, Inc. and not to its subsidiaries. CNO Financial Group, Inc

Annual Report - 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2020 ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-31792 CNO Financi

Subsidiaries of the Registrant.

EX-21.1 8 cno12312020ex21.htm EX-21.1 Exhibit 21 Subsidiaries of CNO Financial Group, Inc. Name State or Other Jurisdiction 40|86 Advisors, Inc. DE 40|86 Mortgage Capital, Inc. DE American Life and Casualty Marketing Division Co. IA Bankers Conseco Life Insurance Company NY Bankers Life Advisory Services, Inc. IN Bankers Life and Casualty Company IL Bankers Life Securities General Agency, Inc. IN

incorporated by reference to Exhibit 10.18 of our Annual Report on Form 10-K for the year ended December 31, 2020

Exhibit 10.18 FIRST AMENDMENT OF THE CNO DEFERRED COMPENSATION PLAN THIS FIRST AMENDMENT OF THE CNO DEFERRED COMPENSATION PLAN (effective as of January 1, 2017) (the ?Plan?) is made by CNO Services, LLC. (the ?Company?), pursuant to action of the Company?s Manager (the ?Manager?), effective January 1, 2017 (the ?Effective Date?). WHEREAS, the Company maintains the Plan; and WHEREAS, Section 12.2 o

incorporated by reference to Exhibit 10.19 of our Annual Report on Form 10-K for the year ended December 31, 2020

EX-10.19 4 cno12312020ex1019.htm EX-10.19 Exhibit 10.19 SECOND AMENDMENT OF THE CNO DEFERRED COMPENSATION PLAN THIS SECOND AMENDMENT OF THE CNO DEFERRED COMPENSATION PLAN (Amended and Restated Effective as of January 1, 2017) (the “Plan”) is made by CNO Services, LLC (the “Company”), pursuant to action of the Company’s Manager (the “Manager”), effective January 1, 2020 (the “Effective Date”). WHER

SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9 )* CNO Financial Group Inc (Name of Issuer) Common Stock (Title of Class of Securities) 12621E103 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: CNO Financial Group Inc. Title of Class of Securities: Common Stock CUSIP Number: 12621E103 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is fi

Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2021 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

Fourth Quarter 2020 Financial and operating results for the period ended December 31, 2020 February 9, 2021 Unless otherwise specified, comparisons in this presentation are between 4Q19 and 4Q20. Exhibit 99.3 CNO Financial Group | Fourth Quarter 2020

EX-99.3 4 exhibit99032020.htm EX-99.3 Fourth Quarter 2020 Financial and operating results for the period ended December 31, 2020 February 9, 2021 Unless otherwise specified, comparisons in this presentation are between 4Q19 and 4Q20. Exhibit 99.3 CNO Financial Group | Fourth Quarter 2020 Earnings | February 9, 2021 2 Important Legal Information Certain statements made in this presentation should b

Quarterly Financial Supplement - 4Q2020 February 9, 2021

Exhibit 99.2 Quarterly Financial Supplement - 4Q2020 February 9, 2021 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance products 7-9 Collected premiums from annuity and interest sensitive life products and insurance policy income 10 Health and life new annualized premiums 11 Computation

CNO Financial Group Reports Fourth Quarter and Full Year 2020 Results Strong fourth quarter earnings; solid capital and liquidity; completed $100 million in share repurchases

Exhibit 99.1 News For Immediate Release CNO Financial Group Reports Fourth Quarter and Full Year 2020 Results Strong fourth quarter earnings; solid capital and liquidity; completed $100 million in share repurchases Carmel, Ind., February 9, 2021 - CNO Financial Group, Inc. (NYSE: CNO) today announced that for the quarter ending December 31, 2020, net income was $111.8 million, or $0.80 per diluted

CNO Financial Group Acquires DirectPath Acquisition enhances Worksite Division growth outlook; Adds key solutions for both employers and employees

EX-99.4 5 exhibit994-12312020directp.htm EX-99.4 Exhibit 99.4 News For Immediate Release CNO Financial Group Acquires DirectPath Acquisition enhances Worksite Division growth outlook; Adds key solutions for both employers and employees CARMEL, Ind. – February 9, 2021 – CNO Financial Group (NYSE: CNO) announced today that it has acquired DirectPath, LLC (“DirectPath”), a leading national provider o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 CNO FINANCIAL GROUP, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) (CUSIP Number) December 31, 2020 (Da

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 CNO FINANCIAL GROUP, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 12621E103 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is file

Investor Overview December 2020 Exhibit 99.1 CNO Financial Group | Investor Overview | December 2020 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private

exhibit991122020 Investor Overview December 2020 Exhibit 99.1 CNO Financial Group | Investor Overview | December 2020 2 Important Legal Information Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution i

Regulation FD Disclosure, Financial Statements and Exhibits - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 8, 2020 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commission

- 8-A12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 CNO FINANCIAL GROUP, INC. (Exact name of registrant as specified in its charter) Delaware (State of incorporation or organization) 75-3108137 (I.R.S. Employer Identification No.) 11825 N. Pennsylva

Second Supplemental Indenture, dated as of November 25, 2020, between CNO Financial Group, Inc. and U.S. Bank National Association, as trustee, relating to the 5.125% Subordinated Debentures due 2060, incorporated by reference to Exhibit 4.2 of our Current Report on Form 8-K filed November 25, 2020.

EXHIBIT 4.2 CNO FINANCIAL GROUP, INC. 5.125% SUBORDINATED DEBENTURES DUE 2060 SECOND SUPPLEMENTAL INDENTURE DATED AS OF NOVEMBER 25, 2020 To the Indenture dated as of June 12, 2019 U.S. BANK National Association, as Trustee TABLE OF CONTENTS Page Article I. DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Incorporation by Reference of TIA 4 Section 1.3 Rules of Co

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits - FORM 8-K

CNO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 25, 2020 CNO Financial Group, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-31792 75-3108137 (State or Other Jurisdiction of Incorporation) (Commis